EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Differences in cytolytic T cell response of BALB/c mice infected with myocarditic and non-myocarditic strains of coxsackievirus group B, type 3



Differences in cytolytic T cell response of BALB/c mice infected with myocarditic and non-myocarditic strains of coxsackievirus group B, type 3



Infection and Immunity 39(3): 1419-1427



Two strains of coxsackie B-3 virus, indistinguishable by neutralization with acute mouse antiserum to coxsackie B-3 group virus, differ markedly in pathogenicity. One strain induces extensive mononuclear cell infiltration and necrosis in the heart, and 92% of the infected animals die by day 10 after infection. Inflammation, cardiac damage, and mortality are reduced in mice infected with the nonmyocarditic virus. Peak virus replication occurs on day 3 with both viruses. Virus concentrations decrease to undetectable levels after day 12 of infection. Cytolytic T cells could be isolated from the spleens of animals inoculated with either virus. The spleen cells preferentially lysed target cells infected with the immunizing virus strain. These results suggest that the myocarditic and nonmyocarditic viruses induce only minimally noncross-reacting virus-specific antigens on the target cell surface.

(PDF emailed within 1 workday: $29.90)

Accession: 042811014

Download citation: RISBibTeXText

PMID: 6301994



Related references

Differing cardiotropic and myocarditic properties of group B type 4 coxsackievirus strains. Archives of Virology 80(2-3): 119-130, 1984

Copper deficiency increases the virulence of amyocarditic and myocarditic strains of coxsackievirus B3 in mice. Journal of Nutrition 138(5): 849-855, 2008

Analysis of the pathogenesis of coxsackievirus B3 myocarditis Comparison of myocarditic and amyocarditic coxsackievirus B3 strains. Nagano, M , Takeda, N , Dhalla, N S The cardiomyopathic heart 309-312, 1994

Characterization and myocarditic capabilities of coxsackievirus B3 variants in selected mouse strains. Journal of Virology 52(2): 598-605, 1984

Properties of coxsackievirus B3 variants which are amyocarditic or myocarditic for mice. Journal of Medical Virology 3(3): 207-220, 1979

Repetitive coxsackievirus infection induces cardiac dilatation in post-myocarditic mice. Japanese Circulation Journal 63(10): 794-802, 1999

Differential Th1 and Th2 cell responses in male and female BALB/c mice infected with coxsackievirus group B type 3. Journal of Virology 68(8): 5126-5132, 1994

In situ hybridization evidence of persistent coxsackievirus infection on post viremic immunosuppression with fk506 in myocarditic mice. Laboratory Investigation 66(1): 21A, 1992

Differential effects of myocarditic variants of Coxsackievirus B3 in inbred mice. A pathologic characterization of heart tissue damage. Laboratory Investigation; A Journal of Technical Methods and Pathology 64(1): 55-64, 1991

Cardiac injury in myocarditis induced by Coxsackievirus group B, type 3 in Balb/c mice is mediated by Lyt 2 + cytolytic lymphocytes. Cellular Immunology 88(2): 558-567, 1984

Immunosuppression increases cardiovirulence of non-myocarditic coxsackievirus B 3. Circulation 94(8 SUPPL ): I674, 1996

Monoclonal antibodies for study of antigenic variation in coxsackievirus type B4: association of antigenic determinants with myocarditic properties of the virus. Journal of General Virology 65: 925-932, 1984

Myocarditic coxsackievirus B3 interactions with cellular elements of the murine spleen. Journal of Molecular & Cellular Cardiology 28(6): A149, 1996

A mutation in the NImII loop of VP2 of coxsackievirus B3 alters viral myocarditic potential. Circulation 92(8 SUPPL ): I527, 1995

Demonstration of suppressor cells in coxsackievirus group B, type 3 infected female Balb/c mice which prevent myocarditis. Cellular Immunology 98(1): 104-113, 1986